About us
The independent Institute for Quality and Efficiency in Health Care (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen, IQWiG) examines the benefits and harms of medical interventions for patients.
Projects
Participation
Events
Press
Contact
Breadcrumbs
Introduction to the topic
Dr Beate Wieseler
Criteria for checking the applicability of study results
PD Dr Ulrich Grouven
Approval studies and therapeutic indication - experience from the early benefit assessment
Dr Thomas Kaiser
From clinical data to therapeutic indication – a compass for the benefit assessment?
Dr Karl Broich
New drugs between approval and benefit assessment – how do manufacturers manage?
Professor Dr Torsten Strohmeyer
Importance of approval status for G-BA decisions
Max Grüne
Programme_IQWiG_in_Dialogue_2013.pdf
